|
|
| Line 37: |
Line 37: |
| <span style="display:none">hasCancerType::C00-D48: All neoplasms</span> | | <span style="display:none">hasCancerType::C00-D48: All neoplasms</span> |
| <span style="display:none">hasCancerType::C00-C97: All cancer types</span> | | <span style="display:none">hasCancerType::C00-C97: All cancer types</span> |
| <span style="display:none">hasCancerType::C00-C14: Mouth/throat cancers</span>
| |
| <span style="display:none">hasCancerType::C30-C39: Lung/chest cancers</span>
| |
| <span style="display:none">hasCancerType::C40-C41: Bone cancers</span>
| |
| <span style="display:none">hasCancerType::C43-C44: Skin cancers/melanoma</span>
| |
| <span style="display:none">hasCancerType::C45-C49: Soft tissue cancer</span>
| |
| <span style="display:none">hasCancerType::C51-C58: Female genitalia cancers</span>
| |
| <span style="display:none">hasCancerType::C60-C63: Male genitalia cancer</span>
| |
| <span style="display:none">hasCancerType::C64-C68: Urinary system cancers</span>
| |
| <span style="display:none">hasCancerType::C69-C72: Eye and brain cancer</span>
| |
| <span style="display:none">hasCancerType::C73-C75: Thyroid and other gland cancers</span>
| |
| <span style="display:none">hasCancerType::C76-C80: Cancers of unknown or unspecified areas</span>
| |
| <span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span>
| |
| <span style="display:none">hasCancerType::C97-C97: Cancers in multiple locations from the start</span>
| |
| <span style="display:none">hasCancerType::D00-D09: Early-stage cancers not yet spread</span>
| |
| <span style="display:none">hasCancerType::D10-D36: Benign tumour</span>
| |
| <span style="display:none">hasCancerType::D37-D48: Growths of uncertain nature</span>
| |
| <span style="display:none">hasCancerType::unknown</span>
| |
Revision as of 19:09, 10 December 2025
forpolicymakers
europeanunion
Go back to European Union page
Primary purpose: To enhance the quality and accessibility of breast and colorectal cancer prevention, screening, and care in Europe by developing evidence-based guidelines and a voluntary quality assurance scheme for these services.
Sponsor, manager or home institution: European Commission.
Type of information: Evidence-based Approach; Multidisciplinary Collaboration; Patient-Centered Focus; Guidelines and Quality Assurance Scheme; Support for Implementation; Conflict of Interest Management; Evolution from Breast Cancer Initiative; Additional Tools. Click here to learn more.
Data level: european level.
Cancer areas of interest: C15-C26: Digestive system cancers; C50: Breast cancer. Click here to learn more.
Access to information: Click here to access.
Esophagus
Stomach
Small intestine
Large intestine
Rectum
Anus
Liver
Gallbladder
Bile ducts
Pancreas
Colon
Lobular
Breast
Nipple
Areola
Ductal
dataOwner::European Commission
dataLevel::european level
hasCancerType::C15-C26: Digestive system cancers
hasCancerType::C50: Breast cancer
hasCancerType::C00-D48: All neoplasms
hasCancerType::C00-C97: All cancer types
